'We are changing the way we disinfect our world'

Christine Brander
Chief Executive Officer & Founder

Our mission is simple, to bring about a change in how we protect both us and our world.

Residual Barrier Technology has developed disinfectant solutions with 3 levels of protection. Not only are they less harmful, they also provide 99.999% effectiveness, and up to 24hr residual protection.

Putting life and our environment first, RBT has developed a range of disinfectants and applications that are clinically tested to perform better, protect longer, less harmful, save time and money in application.

CORONAVIRUS UPDATE

ProtectUs Viridis is effective against Coronavirus. Find out more
Read Sunway University Laboratory test findings. Click here

 Is your hand sanitiser damaging your skin? Viridis is dermatologically proven for use on sensitive skin. 

Read the report:  Click here

• 
  FOOD & DRINK
  

  Whether you're in agriculture, bottling, hatcheries, salad growing, food processing, storage or warehousing, RBT solutions are perfect for making your products safer, more desirable, reducing spoilage and making your product last longer. 
  

  More...
• 
  MEDICAL & HEALTHCARE

  From operating theatres and medical equipment to wards, clinics and care homes. For environments that need to be sterile, RBTs' medical solutions are improving health and hygiene around the world.
  

  More...
• 
  ANIMAL & PET WELFARE
  

  From livestock to domestic pets, our animals need just as much care as we do. RBTs' range of disinfectants is extremely effective against harmful pathogens and harmless to your animals.
  

  More...
• 
  PROFESSIONAL CLEANING
  

  RBT disinfectants have proven to be effective and long lasting in surface sanitisers, hand hygiene, soaps and sanitisers.

  More...

FACT:
33,000 people die
​every year due to infections with antibiotic-resistant bacteria, in EU/EEA. 

33,000 people die every year due to infections with antibiotic-resistant bacteria in the EU and EEA. 39% of this burden is caused by infections with bacteria resistant to last-line antibiotics (European Centre for Disease Prevention).

Prevention via disinfectants reduces antibiotic use, reducing development of resistant strains.
​Source: The Lancet

Who we are

Residual Barrier Technology (RBT) is a ground breaking company in the field of micro biology.

Led by a group of innovative and commercially aware entrepreneurs and partnered by leading International manufacturers, RBT's mission is to protect us and our world.

MEET THE TEAM